ReportingVerified newsroom

Closing the data loop in AI-driven drug discovery

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Tod…

MIT Tech Review AI· MIT Technology Review Insights·Monday, July 27, 2026 at 11:40 AM UTC
OA
OpenAI
Frontier AI lab · OpenAI
Fetching source· Pulling live content from technologyreview.com…
Company hub:OpenAI News →
More from OpenAI